| Literature DB >> 36042635 |
Sang Gyu Kwak1, Hyun Jung Jung2, Won-Kee Choi3.
Abstract
BACKGROUND: We aimed to comparatively analyze the effect of integrative medicine treatments (lifestyle change education, use of anti-inflammatory drugs, acupuncture, manual therapy-type massage) and conventional medical treatments (lifestyle change education and use of anti-inflammatory drugs) on pain control, knee function improvement, and quality of life improvement in patients with degenerative knee arthritis.Entities:
Mesh:
Year: 2022 PMID: 36042635 PMCID: PMC9410661 DOI: 10.1097/MD.0000000000030385
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1.Patient flow chart including the number of screening, enrollment, dropout, and final patient count.
Demographic characteristics between experimental group and control group.
| Variable | Experimental group (n = 12) | Control group (n = 14) | ||
|---|---|---|---|---|
| Age (yr) | 60.33 ± 7.9 | 64.86 ± 6.61 | .125 | |
| BMI (kg/m2) | 25.73 ± 1.79 | 25.9 ± 3.77 | .890 | |
| K-L grade | 1 | 4 (33.3) | 2 (14.3) | .479 |
| 2 | 6 (50) | 8 (57.1) | ||
| 3 | 2 (16.7) | 4 (28.6) | ||
| Sex | Male | 3 (25) | 2 (14.3) | .490 |
| Female | 9 (75) | 12 (85.7) | ||
| Medical history | No | 11 (91.7) | 11 (78.6) | .356 |
| Yes | 1 (8.3) | 3 (21.4) | ||
| Detail | Eye | 0 | 1 | - |
| Endocrine | 0 | 1 | ||
| Cardiovascular | 1 | 1 | ||
| Digestive | 0 | 1 | ||
| etc | 0 | 1 | ||
Values were presented by mean ± standard deviation or frequency (percent).
BMI = body mass index, K-L = Kellgren-Lawrence.
Comparison for VAS and functional outcomes between experimental group and control group.
| Variable | Group | Visit, mean ± SD | |||||
|---|---|---|---|---|---|---|---|
| V1 (pre) | V2 (6 weeks) | V3 (12 weeks) | V | G | V*G | ||
| VAS | Exp | 5.13 ± 0.80 | 1.96 ± 0.94 | 2.83 ± 1.23 | <.001 | .340 | <.001 |
| Con | 4.29 ± 1.33 | 3.57 ± 1.60 | 3.32 ± 1.90 | ||||
| WOMAC pain | Exp | 6.92 ± 3.63 | 3.42 ± 2.47 | 5.25 ± 2.86 | .076 | .639 | .099 |
| Con | 6.00 ± 3.44 | 5.86 ± 2.38 | 4.93 ± 4.03 | ||||
| WOMAC stiffness | Exp | 4.00 ± 1.91 | 2.42 ± 1.62 | 2.25 ± 1.42 | .005 | .705 | .261 |
| Con | 3.07 ± 1.77 | 2.57 ± 1.65 | 2.43 ± 1.91 | ||||
| WOMAC body function | Exp | 30.25 ± 12.41 | 16.08 ± 8.74 | 16.83 ± 7.78 | <.001 | .794 | .094 |
| Con | 23.57 ± 11.20 | 19.07 ± 8.69 | 18.29 ± 9.88 | ||||
| WOMAC total | Exp | 41.17 ± 16.62 | 21.92 ± 11.97 | 24.33 ± 10.59 | <.001 | .890 | .093 |
| Con | 32.64 ± 15.06 | 27.5 ± 11.82 | 25.64 ± 15.14 | ||||
P values were obtained by repeated-measure 2 factor analysis.
Con = control, Exp = experimental, G = group, SD = standard deviation, V = visit, VAS = Visual Analog Scale, WOMAC = Western Ontario and McMaster Universities.
Statistically significant with P < .05.
Figure 2.Result of VAS by 3 visits (pre, 6 weeks, and 12 weeks) between groups (experimental group and control group). VAS = Visual Analog Scale.
Comparison for quality of life between experimental group and control group.
| Variable | Group | Visit, mean ± SD | |||||
|---|---|---|---|---|---|---|---|
| V1 (pre) | V2 (6 weeks) | V3 (12 weeks) | V | G | V*G | ||
| PCS | Exp | 45.42 ± 12.85 | 61.28 ± 8.86 | 55.44 ± 9.32 | .002 | .107 | .112 |
| Con | 45.07 ± 12.87 | 49.22 ± 12.08 | 50.69 ± 13.83 | ||||
| MCS | Exp | 56.05 ± 12.01 | 67.76 ± 9.79 | 64.12 ± 11.29 | .006 | .465 | .237 |
| Con | 56.62 ± 11.85 | 60.08 ± 13.07 | 62.79 ± 13.93 | ||||
| PF | Exp | 46.67 ± 14.51 | 63.33 ± 18.38 | 56.67 ± 14.67 | .017 | .653 | .533 |
| Con | 47.5 ± 22.08 | 55.36 ± 17.81 | 56.79 ± 19.77 | ||||
| RPH | Exp | 52.08 ± 24.76 | 78.65 ± 11.45 | 72.4 ± 18.36 | .003 | .051 | .024 |
| Con | 50.45 ± 26.23 | 53.13 ± 25.68 | 54.02 ± 24.10 | ||||
| BP | Exp | 39.17 ± 8.00 | 50.63 ± 16.72 | 46.88 ± 12.84 | .047 | .291 | .629 |
| Con | 39.46 ± 14.94 | 45.18 ± 11.16 | 41.61 ± 11.71 | ||||
| GH | Exp | 43.75 ± 18.96 | 52.50 ± 19.25 | 45.83 ± 18.07 | .484 | .667 | .303 |
| Con | 42.86 ± 12.36 | 43.21 ± 13.53 | 50.36 ± 19.56 | ||||
| REP | Exp | 60.42 ± 25.90 | 83.33 ± 17.41 | 75.69 ± 22.04 | .008 | .320 | .268 |
| Con | 60.71 ± 24.11 | 67.86 ± 23.99 | 67.86 ± 27.32 | ||||
| EF | Exp | 51.25 ± 8.01 | 50.42 ± 8.38 | 49.58 ± 10.54 | .863 | .018 | .570 |
| Con | 53.57 ± 8.19 | 56.79 ± 7.50 | 56.07 ± 6.84 | ||||
| SF | Exp | 63.54 ± 19.55 | 73.96 ± 19.55 | 71.88 ± 12.07 | .066 | .510 | .348 |
| Con | 61.61 ± 17.99 | 63.39 ± 22.18 | 73.21 ± 18.90 | ||||
| EWB | Exp | 49.00 ± 9.96 | 63.33 ± 7.78 | 59.33 ± 9.47 | .000 | .107 | .006 |
| Con | 50.57 ± 8.09 | 52.29 ± 9.60 | 54.00 ± 10.50 | ||||
P values were obtained by repeated-measure 2 factor analysis.
BP = body pain, C = control, EF = energy/fatigue, EWB = emotional well-being, Exp = experimental, G = group, GH = general health, MCS = mental component score, PCS = physical component score, PF = physical functioning, REP = role limitations due to emotional problems, RPH = role limitations due to physical health, SD = standard deviation, SF = social functioning, V = visit.
Statistically significant with P < .05.
Figure 3.Result of 2 subdomains of SF-36, role limitations due to physical health (A) and emotional well-being (B) by 4 visits (pre, 2 weeks, 6 weeks, and 12 weeks) between group (experimental group and control group).